ABCB1 and leukemia: MDR1/P-gp expression can be altered, either directly or indirectly, by modulating the levels of miR-381 or miR-495 in K562/ADM cells, hence affecting the substrate efflux function of P-gp, demonstrating the capacity of miR treatment to increase drug uptake in MDR leukemia cells.